Advertisement

More articles from Research Articles

  • Role of Mirc11 in NK Cell–Mediated Anticancer Responses
    Arash Nanbakhsh, Anupallavi Srinivasamani, Sandra Holzhauer, Matthew J. Riese, Yongwei Zheng, Demin Wang, Robert Burns, Michael H. Reimer, Sridhar Rao, Angela Lemke, Shirng-Wern Tsaih, Michael J. Flister, Shunhua Lao, Richard Dahl, Monica S. Thakar, Subramaniam Malarkannan
    Cancer Immunology Research Oct 2019, 7 (10) 1647-1662; DOI: 10.1158/2326-6066.CIR-18-0934
  • CD4+ T-cell Responses against the Merkel Cell Polyomavirus
    Natalie V. Longino, Junbao Yang, Jayasri G. Iyer, Dafina Ibrani, I-Ting Chow, Kerry J. Laing, Victoria L. Campbell, Kelly G. Paulson, Rima M. Kulikauskas, Candice D. Church, Eddie A. James, Paul Nghiem, William W. Kwok, David M. Koelle
    Cancer Immunology Research Oct 2019, 7 (10) 1727-1739; DOI: 10.1158/2326-6066.CIR-19-0103
  • TAM RTK Inhibition Reverses MDSC Suppression and Augments PD-1
    Alisha Holtzhausen, William Harris, Eric Ubil, Debra M. Hunter, Jichen Zhao, Yuewei Zhang, Dehui Zhang, Qingyang Liu, Xiaodong Wang, Douglas K. Graham, Stephen V. Frye, H. Shelton Earp
    Cancer Immunology Research Oct 2019, 7 (10) 1672-1686; DOI: 10.1158/2326-6066.CIR-19-0008
  • CD47 Impacts Response of Non-GCB DLBCL Patients upon R-CHOP
    Renée Bouwstra, Yuan He, Janneke de Boer, Hilde Kooistra, Ewa Cendrowicz, Rudolf S.N. Fehrmann, Emanuele Ammatuna, Christine zu Eulenburg, Marcel Nijland, Gerwin Huls, Edwin Bremer, Tom van Meerten
    Cancer Immunology Research Oct 2019, 7 (10) 1663-1671; DOI: 10.1158/2326-6066.CIR-18-0781
  • Mediators of MDSC Expansion, Trafficking, and Function
    Charles S. Tannenbaum, Patricia A. Rayman, Paul G. Pavicic, Jin Sub Kim, Wei Wei, Alexandra Polefko, Wesley Wallace, Brian I. Rini, Gareth Morris-Stiff, Daniela S. Allende, Thomas Hamilton, James H. Finke, C. Marcela Diaz-Montero
    Cancer Immunology Research Oct 2019, 7 (10) 1687-1699; DOI: 10.1158/2326-6066.CIR-18-0578
  • Intratumoral Cytotoxic CD8+PD1-ILT2+ T Cells
    Clement Dumont, Alix Jacquier, Jerome Verine, Floriane Noel, Annabelle Goujon, Ching-Lien Wu, Tzu-Min Hung, François Desgrandchamps, Stephane Culine, Edgardo D. Carosella, Nathalie Rouas-Freiss, Joel LeMaoult
    Cancer Immunology Research Oct 2019, 7 (10) 1619-1632; DOI: 10.1158/2326-6066.CIR-18-0764
  • Elotuzumab Promotes SLAMF7–SLAMF7 Interactions and Signaling
    Tatiana Pazina, Ashley M. James, Kimberly B. Colby, Yibin Yang, Andrew Gale, Amy Jhatakia, Alper Y. Kearney, Robert F. Graziano, Natalie A. Bezman, Michael D. Robbins, Adam D. Cohen, Kerry S. Campbell
    Cancer Immunology Research Oct 2019, 7 (10) 1633-1646; DOI: 10.1158/2326-6066.CIR-18-0579
  • IRE Acts as an In Situ Vaccine against Pancreatic Cancer
    Jayanth S. Shankara Narayanan, Partha Ray, Tomoko Hayashi, Thomas C. Whisenant, Diego Vicente, Dennis A. Carson, Aaron M. Miller, Stephen P. Schoenberger, Rebekah R. White
    Cancer Immunology Research Oct 2019, 7 (10) 1714-1726; DOI: 10.1158/2326-6066.CIR-19-0101
  • Glutaminolysis Controls IMC Generation in Cancers
    Wen-Chao Wu, Hong-Wei Sun, Jing Chen, Han-Yue OuYang, Xing-Juan Yu, Hai-Tian Chen, Ze-Yu Shuang, Ming Shi, Zilian Wang, Limin Zheng
    Cancer Immunology Research Oct 2019, 7 (10) 1605-1618; DOI: 10.1158/2326-6066.CIR-18-0902
  • Blockade of TIGIT/CD155 Signaling in HNSCC
    Lei Wu, Liang Mao, Jian-Feng Liu, Lei Chen, Guang-Tao Yu, Lei-Lei Yang, Hao Wu, Lin-Lin Bu, Ashok B. Kulkarni, Wen-Feng Zhang, Zhi-Jun Sun
    Cancer Immunology Research Oct 2019, 7 (10) 1700-1713; DOI: 10.1158/2326-6066.CIR-18-0725

Pages